GMDA News and Press, Gamida Cell Ltd. From 03/27/24

A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 34.1% to $0.3754 on volume of 55,110,141 shares Gamida Cell Ltd. (GMDA) fell 82.7% to $0.0594 on volume of 50,587,982 shares iBio Inc. (IBIO) rose 111.3% to $2.43 on volume of 40,863,066 shares...

2024-03-27 07:36:59 ET More on Gamida Cell Gamida Cell stock jumps as company explores strategic alternatives Seeking Alpha’s Quant Rating on Gamida Cell Historical earnings data for Gamida Cell Financial information for Gamida Cell Read the ...

2024-03-27 07:04:21 ET More on Gamida Cell Gamida Cell stock jumps as company explores strategic alternatives Seeking Alpha’s Quant Rating on Gamida Cell Historical earnings data for Gamida Cell Financial information for Gamida Cell Read the ...

Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...

Company announces commencement of restructuring process supported by Highbridge Capital Management Continued progress of launch of Omisirge ® (omidubicel-onlv), with the delivery of six units in 2023, as well as significant transplant center onboarding Company to ...

2024-03-26 09:51:41 ET Major earnings expected before the bell on Wednesday include: Altimmune ( ALT ) Carnival Corporation ( CCL ) Cintas ( CTAS ) Paychex ( PAYX ) Tsakos Energy Navigation ( TNP ) Read the full article on Seeking Alpha ...

BOSTON, March 22, 2024 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that the company will release its financial results for the fourth quarter and full year ended December 31, 2023 and p...

Expanded access program (EAP) data for omidubicel are consistent with Phase 3 trial results on rates of hematopoietic recovery and infections following stem cell transplant with Omisirge ® (omidubicel-onlv) Preliminary data presented on GDA-201, Gamida Cell’s nat...

2024-01-29 06:17:18 ET Read the full article on Seeking Alpha For further details see: Gamida Cell stock jumps as company explores strategic alternatives

BOSTON, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Gamida Cell Ltd . (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced it is actively pursuing strategic alternatives in order to maximize value for all stakeholders, focusing on an asset sale, merge...